A detailed history of Biltmore Family Office, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Biltmore Family Office, LLC holds 18,645 shares of PFE stock, worth $489,244. This represents 0.1% of its overall portfolio holdings.

Number of Shares
18,645
Previous 17,600 5.94%
Holding current value
$489,244
Previous $492,000 9.55%
% of portfolio
0.1%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $28,946 - $32,802
1,045 Added 5.94%
18,645 $539,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $3,961 - $4,548
153 Added 0.88%
17,600 $488,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $57,747 - $75,007
-2,210 Reduced 11.24%
17,447 $502,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $8,568 - $10,015
-267 Reduced 1.34%
19,657 $652,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $58,044 - $67,156
-1,607 Reduced 7.46%
19,924 $730,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $9,532 - $12,409
242 Added 1.14%
21,531 $878,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $11,063 - $14,442
265 Added 1.26%
21,289 $1.09 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $3,106 - $3,792
71 Added 0.34%
21,024 $920,000
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $33,501 - $39,722
-720 Reduced 3.32%
20,953 $1.1 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $34,312 - $42,517
-750 Reduced 3.34%
21,673 $1.12 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $50,534 - $74,908
1,223 Added 5.77%
22,423 $1.32 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $70,650 - $90,756
-1,800 Reduced 7.83%
21,200 $912,000
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $21,366 - $24,204
-595 Reduced 2.52%
23,000 $901,000
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $63,764 - $71,914
-1,904 Reduced 7.47%
23,595 $855,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $123,069 - $156,493
3,677 Added 16.85%
25,499 $939,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $4,222 - $4,954
-133 Reduced 0.61%
21,822 $801,000
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $219,363 - $266,120
-7,283 Reduced 24.91%
21,955 $718,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $258,109 - $368,782
-9,549 Reduced 24.62%
29,238 $954,000
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $257,006 - $291,669
-7,807 Reduced 16.76%
38,787 $1.52 Million
Q3 2019

Oct 16, 2019

BUY
$32.49 - $42.13 $598,173 - $775,655
18,411 Added 65.33%
46,594 $1.67 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $100,178 - $112,477
-2,709 Reduced 8.77%
28,183 $1.22 Million
Q1 2019

Apr 12, 2019

SELL
$37.5 - $41.2 $33,675 - $36,997
-898 Reduced 2.82%
30,892 $1.31 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $24,313 - $27,719
632 Added 2.03%
31,790 $1.39 Million
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $75,902 - $92,065
-2,202 Reduced 6.6%
31,158 $1.37 Million
Q2 2018

Jul 17, 2018

SELL
$32.98 - $35.16 $1.67 Million - $1.78 Million
-50,620 Reduced 60.28%
33,360 $1.21 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $77,062 - $89,403
-2,415 Reduced 2.8%
83,980 $2.98 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $2.87 Million - $3.05 Million
86,395
86,395 $3.13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Biltmore Family Office, LLC Portfolio

Follow Biltmore Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.